PTSD Trial, Recruiting (NCT06700590)

PTSD Trial, Recruiting NCT06700590 Sponsor: ARQ National Psychotrauma Centre Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT06700590 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with PTSD based on a standard psychiatric assessment (DSM-5 criteria)
Your PTSD developed as a result of 2 or more traumatic events
You are seeking treatment for PTSD for the first time, or have had fewer than 8 therapy sessions for PTSD so far
You are currently working, or have been on sick leave for less than two years

Who may not be able to join:

You currently have a psychotic disorder, a severe alcohol or drug use problem, a high level of suicidal intent with a specific plan to act on it, or a history of severe aggressive behaviour that puts others at risk
You do not have a sufficient understanding of the Dutch language to complete the study assessments (this will be judged by a clinician at your initial appointment)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mirjam Mink-Nijdam, PhD, ARQ National Psychotrauma Center

Phone: +31(0)20 840 7640

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06700590

Sponsor: ARQ National Psychotrauma Centre

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: +31(0)20 840 7640

More information: https://clinicaltrials.gov/study/NCT06700590

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have been diagnosed with PTSD based on a standard psychiatric assessment (DSM-5 criteria)
Your PTSD developed as a result of 2 or more traumatic events
You are seeking treatment for PTSD for the first time, or have had fewer than 8 therapy sessions for PTSD so far
You are currently working, or have been on sick leave for less than two years

Who may not be able to join:

You currently have a psychotic disorder, a severe alcohol or drug use problem, a high level of suicidal intent with a specific plan to act on it, or a history of severe aggressive behaviour that puts others at risk
You do not have a sufficient understanding of the Dutch language to complete the study assessments (this will be judged by a clinician at your initial appointment)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

ARQ National Psychotrauma Centre

Registry

ClinicalTrials.gov

Start date

21 November 2024

Est. completion

1 April 2028

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Clinician Administered PTSD Scale for DSM-5 (CAPS-5); Cost-effectiveness (Quality of life); Cost-effectiveness (Mental Health Quality of Life Questionnaire); Cost-effectiveness (Treatment inventory of costs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov